IMR Press / EJGO / Volume 23 / Issue 4 / pii/2002174

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research

Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII

Show Less
1 Division of Gynecological Surgery, Department of Gynecology and Obstetrics, Karol Marcinkowski University of Medical Sciences, Poznan (Poland)
Eur. J. Gynaecol. Oncol. 2002, 23(4), 325–326;
Published: 10 August 2002

The authors report two cases of successful employment of human recombinant activated factor VII in gynecological oncological patients (endometrial cancer and vaginal sarcoma) without pre-existing coagulopathy. They conclude that recombinant factor VIIa may be an important and effective drug in severe bleeding in gynecological oncology.

Recombinant factor Vila
Cancer of endometrium
Vaginal sarcoma
Back to top